↓ Skip to main content

Checkpoint inhibitors in hematological malignancies

Overview of attention for article published in Journal of Hematology & Oncology, May 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#37 of 1,307)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
8 news outlets
twitter
2 X users

Citations

dimensions_citation
110 Dimensions

Readers on

mendeley
170 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Checkpoint inhibitors in hematological malignancies
Published in
Journal of Hematology & Oncology, May 2017
DOI 10.1186/s13045-017-0474-3
Pubmed ID
Authors

Chi Young Ok, Ken H. Young

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 170 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 <1%
Unknown 169 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 15%
Researcher 24 14%
Student > Ph. D. Student 24 14%
Student > Bachelor 17 10%
Other 16 9%
Other 31 18%
Unknown 33 19%
Readers by discipline Count As %
Medicine and Dentistry 50 29%
Biochemistry, Genetics and Molecular Biology 24 14%
Agricultural and Biological Sciences 17 10%
Immunology and Microbiology 9 5%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Other 18 11%
Unknown 43 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 63. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2017.
All research outputs
#688,287
of 25,837,817 outputs
Outputs from Journal of Hematology & Oncology
#37
of 1,307 outputs
Outputs of similar age
#13,890
of 326,169 outputs
Outputs of similar age from Journal of Hematology & Oncology
#1
of 48 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,307 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,169 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.